First, Do NoHarm: How Pharmaceutical AI Is Improving Care Across Brazil
No source abstract was supplied.
Record details
Published: 22 July 2026
Source: JMIR (Journal of Medical Internet Research)
Category: Research
Topics: Biotech
Retrieved: 23 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Antigen-specific Antibody Multi-modal Foundation Model for Functional Antibody Design
arXiv cs.LG · 22 July 2026
From mechanistic models to artificial intelligence: exploring the potential of digital twins in geriatric oncology
Frontiers in Artificial Intelligence · 23 July 2026
A Drift Stable Quantum Federated Learning for Intelligent Services
arXiv fairness query · 22 July 2026
SoK: Adversarial Robustness of the Variational Quantum Eigensolver via Red-Teaming
arXiv red teaming query · 21 July 2026
BioSecBench-Surveillance: A Verifiable Benchmark for AI Agents in Pathogen Genomic Surveillance
arXiv cs.AI · 21 July 2026
Bizarre CRISPR enzyme kills cancer cells by shredding their DNA
Nature Machine Intelligence · 23 July 2026
How to cite this record
ethics.ai (22 July 2026), “First, Do NoHarm: How Pharmaceutical AI Is Improving Care Across Brazil,” evidence record 12763, https://ethics.ai/record/12763 (originally published by JMIR (Journal of Medical Internet Research)).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.